நோவர்த்திச் ஆஸ்திரேலியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நோவர்த்திச் ஆஸ்திரேலியா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நோவர்த்திச் ஆஸ்திரேலியா Today - Breaking & Trending Today

Australian meds placed illegally on government register though direct order


Australian meds placed illegally on government register though direct order
Novartis agent says health ministry’s CPSU has given €98,000 direct order to newly-incorporated company for medicinal that is legally not even for sale in Europe
11 May 2021, 8:54am
by Matthew Vella
Malta’s central procurement unit (CPSU) for medicines has been acquiring an imported Australian product that could have been illegally placed on the Maltese market.
Novartis agents V.J.Salomone Pharma believes the health ministry’s CPSU has been acquiring illegally-imported versions of their Novartis product, Cosentyx.
The matter was considered serious enough for top brass from the Novartis pharmaceutical company in Switzerland to file a complaint directly with Prime Minister Robert Abela about illegal procurement practices in 2020. ....

V Jsalomone Pharma , Robert Abela , Chris Fearne , Lewis Campbell , Healthcare Ltd , Novartis Pharmaceuticals Australia Pty , Salomone Pharma , Prime Minister Robert Abela , Target Healthcare Ltd , Target Healthcare , European Economic Area , Novartis Australia , Prime Minister Chris Fearne , ராபர்ட் அபேலா , லெவிஸ் கேம்ப்பெல் , சுகாதாரம் லிமிடெட் , ப்ரைம் அமைச்சர் ராபர்ட் அபேலா , இலக்கு சுகாதாரம் , ஐரோப்பிய பொருளாதார பரப்பளவு , நோவர்த்திச் ஆஸ்திரேலியா ,

TGA approves first Australian commercial CAR-T manufacturing site


Date Time
TGA approves first Australian commercial CAR-T manufacturing site
The TGA has approved Cell Therapies to commence the commercial production of Novartis’ CAR-T cell therapy KYMRIAH at the Peter MacCallum Cancer Centre in Melbourne.
Novartis said the approval makes Cell Therapies the first and only approved commercial manufacturing site for CAR-T in Australia.
KYMRIAH was the first CAR-T therapy approved and publicly funded in Australia. It is currently funded for the treatment of relapsed or refractory DLBCL (diffuse large B cell lymphoma) and paediatric and young adult patients up to 25 years of age with relapsed or refractory ALL (acute lymphoblastic leukaemia). ....

Simon Harrison , Cheryl Maley , Centre Of Excellence , Peter Maccallum Cancer Centre , Cell Therapies , New South Wales , Novartis Australia , Associate Professor Dominic Wall , Good Manufacturing Practice , Associate Professor , Professor Simon Harrison , Peter Maccallum Cancer , Biotechnology Industry , Western Australia , Manufacturing Facility , Clinical Trials , Cell Therapy , சிமோன் ஹாரிசன் , செரில் மலேய் , மையம் ஆஃப் சிறப்பானது , பீட்டர் மக்காலம் புற்றுநோய் மையம் , செல் சிகிச்சைகள் , புதியது தெற்கு வேல்ஸ் , நோவர்த்திச் ஆஸ்திரேலியா , இணை ப்ரொஃபெஸர் ஆதிக்கம் செலுத்தும் சுவர் , நல்ல உற்பத்தி ப்ர்யாக்டீஸ் ,